Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)
CNY 15.64
(0.77%)
CNY 15.64
(0.77%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 419.8 Million CNY | -35.89% |
| 2022 | 175.67 Million CNY | 28.31% |
| 2021 | 136.9 Million CNY | 33.76% |
| 2020 | 102.35 Million CNY | -53.51% |
| 2019 | 220.14 Million CNY | 2.39% |
| 2018 | 215.01 Million CNY | 64.6% |
| 2017 | 130.62 Million CNY | -0.5% |
| 2016 | 131.28 Million CNY | -1.75% |
| 2015 | 133.62 Million CNY | 23.98% |
| 2014 | 107.78 Million CNY | -69.03% |
| 2013 | 347.96 Million CNY | -2.8% |
| 2012 | 357.98 Million CNY | -7.26% |
| 2011 | 386 Million CNY | 47.6% |
| 2010 | 261.51 Million CNY | 33.92% |
| 2009 | 195.27 Million CNY | 13.29% |
| 2008 | 172.36 Million CNY | 11.39% |
| 2007 | 154.73 Million CNY | 31.97% |
| 2006 | 117.25 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 38.11 Million CNY | 328.06% |
| 2024 Q2 | 39.14 Million CNY | 2.69% |
| 2024 Q3 | 2.47 Million CNY | 106.06% |
| 2023 Q4 | -16.71 Million CNY | -105.59% |
| 2023 FY | 112.62 Million CNY | -35.89% |
| 2023 Q1 | 55.1 Million CNY | 363.47% |
| 2023 Q2 | 49.83 Million CNY | -9.58% |
| 2023 Q3 | 298.78 Million CNY | 499.61% |
| 2022 Q1 | 50.72 Million CNY | 193.22% |
| 2022 FY | 175.67 Million CNY | 28.31% |
| 2022 Q4 | -20.91 Million CNY | -141.54% |
| 2022 Q3 | 50.34 Million CNY | 32.84% |
| 2022 Q2 | 37.9 Million CNY | -25.28% |
| 2021 Q1 | 43.86 Million CNY | 167.7% |
| 2021 Q2 | 31.3 Million CNY | -28.64% |
| 2021 Q3 | 44.43 Million CNY | 41.96% |
| 2021 Q4 | 17.3 Million CNY | -61.07% |
| 2021 FY | 136.9 Million CNY | 33.76% |
| 2020 Q1 | 36.09 Million CNY | -41.74% |
| 2020 Q2 | 31.13 Million CNY | -13.73% |
| 2020 Q3 | 28.58 Million CNY | -8.19% |
| 2020 Q4 | -64.78 Million CNY | -326.63% |
| 2020 FY | 102.35 Million CNY | -53.51% |
| 2019 Q4 | 61.94 Million CNY | 15.23% |
| 2019 Q1 | 52.7 Million CNY | -42.22% |
| 2019 FY | 220.14 Million CNY | 2.39% |
| 2019 Q3 | 53.75 Million CNY | 3.91% |
| 2019 Q2 | 51.73 Million CNY | -1.84% |
| 2018 Q4 | 91.21 Million CNY | 116.79% |
| 2018 FY | 215.01 Million CNY | 64.6% |
| 2018 Q3 | 42.07 Million CNY | 26.15% |
| 2018 Q2 | 33.35 Million CNY | -31.05% |
| 2018 Q1 | 48.37 Million CNY | 249.38% |
| 2017 FY | 130.62 Million CNY | -0.5% |
| 2017 Q1 | 47.21 Million CNY | 16.52% |
| 2017 Q3 | 24.65 Million CNY | -45.1% |
| 2017 Q4 | 13.84 Million CNY | -43.85% |
| 2017 Q2 | 44.91 Million CNY | -4.88% |
| 2016 FY | 131.28 Million CNY | -1.75% |
| 2016 Q1 | 47.97 Million CNY | 3064.26% |
| 2016 Q3 | 12.06 Million CNY | -60.74% |
| 2016 Q2 | 30.72 Million CNY | -35.95% |
| 2016 Q4 | 40.51 Million CNY | 235.84% |
| 2015 FY | 133.62 Million CNY | 23.98% |
| 2015 Q2 | 66.44 Million CNY | 21.95% |
| 2015 Q3 | 14.31 Million CNY | -78.46% |
| 2015 Q4 | -1.61 Million CNY | -111.31% |
| 2015 Q1 | 54.48 Million CNY | 510.96% |
| 2014 Q2 | 33.62 Million CNY | -56.31% |
| 2014 Q4 | -13.25 Million CNY | -226.64% |
| 2014 Q3 | 10.46 Million CNY | -68.86% |
| 2014 Q1 | 76.94 Million CNY | 138.09% |
| 2014 FY | 107.78 Million CNY | -69.03% |
| 2013 Q3 | 71.36 Million CNY | -39.97% |
| 2013 Q2 | 118.87 Million CNY | -5.22% |
| 2013 FY | 347.96 Million CNY | -2.8% |
| 2013 Q4 | 32.31 Million CNY | -54.71% |
| 2013 Q1 | 125.41 Million CNY | 235.03% |
| 2012 Q1 | 115.02 Million CNY | 181.48% |
| 2012 Q4 | 37.43 Million CNY | -57.85% |
| 2012 Q3 | 88.8 Million CNY | -23.92% |
| 2012 Q2 | 116.72 Million CNY | 1.48% |
| 2012 FY | 357.98 Million CNY | -7.26% |
| 2011 Q2 | 85.22 Million CNY | -58.49% |
| 2011 Q1 | 205.31 Million CNY | 471.73% |
| 2011 Q4 | 40.86 Million CNY | -25.15% |
| 2011 FY | 386 Million CNY | 47.6% |
| 2011 Q3 | 54.59 Million CNY | -35.94% |
| 2010 Q2 | 67.55 Million CNY | -29.05% |
| 2010 FY | 261.51 Million CNY | 33.92% |
| 2010 Q3 | 62.84 Million CNY | -6.96% |
| 2010 Q4 | 35.91 Million CNY | -42.86% |
| 2010 Q1 | 95.2 Million CNY | 653.54% |
| 2009 Q4 | 12.63 Million CNY | -68.46% |
| 2009 Q1 | 76.83 Million CNY | 0.0% |
| 2009 Q2 | 65.74 Million CNY | -14.43% |
| 2009 FY | 195.27 Million CNY | 13.29% |
| 2009 Q3 | 40.06 Million CNY | -39.06% |
| 2008 FY | 172.36 Million CNY | 11.39% |
| 2007 FY | 154.73 Million CNY | 31.97% |
| 2006 FY | 117.25 Million CNY | 0.0% |